Go to the list of all blogs
Bort Wilson's Avatar
published in Blogs
Sep 25, 2026
Why Is Scholastic Corporation (SCHL) Stock Down -10.22% Today?

Why Is Scholastic Corporation (SCHL) Stock Down -10.22% Today?

Key Takeaways

  • SCHL shares fell roughly 10.2% to about $31.27, down from the prior session's close of $34.83.
  • The primary catalyst was a first-quarter fiscal 2027 earnings miss: a wider-than-expected adjusted loss and lower-than-forecast revenue.
  • Weakness was concentrated in the Education Solutions segment, where revenue dropped 24% amid school and district budget pressures.
  • Management affirmed its full-year outlook, but investors focused on the top-line shortfall and a seasonally large operating loss.
  • Traders are now watching the critical fall back-to-school season and major franchise releases scheduled for the second half.

Opening Summary

Scholastic Corporation (SCHL), the global children's publishing, education, and media company behind the iconic Scholastic Book Fairs and franchises such as Harry Potter, The Hunger Games, and Dog Man, saw its shares drop sharply in Friday's session. The stock fell about 10.2% to $31.27, down from a prior close of $34.83, following a fiscal first-quarter earnings report released after Thursday's close that missed Wall Street expectations on both the top and bottom lines. Markets attributed the decline primarily to a wider adjusted loss and weaker-than-expected revenue, even as the company reaffirmed its full-year guidance.

Earnings Miss Weighs on Shares

The move was earnings-driven. For the fiscal first quarter ended August 31, 2026, SCHL reported an adjusted loss of $3.63 per share, deeper than the consensus estimate of a $3.40 loss. Revenue fell 4% year over year to $216.8 million, coming in below the roughly $230 million analysts had projected and down from $225.6 million a year earlier. Adjusted EBITDA was a loss of $63.6 million, compared with a loss of $55.7 million in the prior-year period.

The company framed the quarter as its seasonally smallest, with schools largely out of session during the summer months. However, the magnitude of the shortfall, combined with a widening adjusted operating loss of $88.7 million, prompted investors to reassess the pace of the company's recovery. Despite the miss, management reiterated its fiscal 2027 outlook for revenue growth of approximately 2% to 4%, adjusted EBITDA of $135 million to $145 million, and free cash flow of $35 million to $40 million.

Education Segment Under Pressure

A key source of the disappointment was the Education Solutions division, where revenue tumbled 24% to $30.4 million from $40.1 million in the prior-year period. The segment continues to contend with the expiration of federal ESSER funding, declining enrollment, rising fixed costs, and constrained budgets at schools and districts for supplemental curriculum materials. The Children's Book Publishing and Distribution segment also slipped 3% to $105.8 million, partly reflecting lower trade sales.

Those declines were partially offset by standout growth in Entertainment, where revenue surged 48% to $20.1 million on higher production activity, and by a 2% rise in International revenue to $60.5 million. Still, the strength in these smaller segments was not enough to offset the drag from Education and the broader top-line shortfall.

Market Context and Trading Activity

The selloff reflected an earnings-driven market reaction rather than a broad market move. SCHL traded well below its 50-day and 200-day moving averages during the session, signaling that the decline pushed the stock through key technical support levels. Trading volume was elevated relative to the stock's typical daily average as investors digested the report. The stock remains within its 52-week range of roughly $25.91 to $48.07, but Friday's drop erased much of its recent momentum and moved shares toward the lower portion of that range.

Insider selling had also been a notable theme in recent months, and the company's free cash flow use widened to $110.8 million, reflecting typical seasonal working-capital patterns. These factors added to a cautious tone among investors despite management's reaffirmed guidance and an improved balance sheet that saw net debt fall to $86.8 million from $242.8 million a year earlier.

What Comes Next for SCHL

Looking ahead, the focus shifts to execution during the critical fall and holiday selling season. Management highlighted that Book Fairs bookings and fair counts are running ahead of the prior year, and the company enters the second quarter with a strong publishing slate, including Harry Potter titles ahead of HBO's planned series and Dav Pilkey's "Dog Man: A Sprinkle in Time." These franchise-driven catalysts, along with stabilization in the Education segment, will be central to whether SCHL can deliver the sequential improvement needed to hit its full-year targets.

Risks remain. Continued budget pressure in school districts, the lingering effects of sale-leaseback transactions completed in December 2025, and the company's reliance on a strong second half all present uncertainties. Investors will also monitor the next quarterly earnings report and any updates to full-year guidance for signs that the seasonal recovery is materializing as expected.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots designed to navigate shifting market conditions. Tickeron offers hundreds of these automated bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a range of approaches to explore. For those looking to complement their own research with data-driven, automated tools, the Trending AI Robots page is a useful starting point.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHL

Contributor

Bort Wilson's AvatarBort Wilson|Beginner

With a background in economics and swing trading, I write about market trends, technical setups, momentum, and opportunities that develop over several days or weeks. I combine economic perspective with practical trading experience to explain why stocks move, what trends may be developing, and which market signals are worth watching.


SCHL's RSI Indicator descending into oversold zone

The RSI Indicator for SCHL moved into overbought territory on September 24, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 55 cases where SCHL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for SCHL just turned positive on September 22, 2026. Looking at past instances where SCHL's MACD turned positive, the stock continued to rise in 27 of 40 cases over the following month. The odds of a continued upward trend are 68%.

Following a +1.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHL advanced for three days, in 249 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

SCHL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHL as a result. In 59 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

The Aroon Indicator for SCHL entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.866) is normal, around the industry mean (8.395). P/E Ratio (14.885) is within average values for comparable stocks, (19.323). Projected Growth (PEG Ratio) (1.685) is also within normal values, averaging (5.359). Dividend Yield (0.024) settles around the average of (0.019) among similar stocks. P/S Ratio (0.535) is also within normal values, averaging (1.204).

The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. SCHL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCHL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

Industry description

The newspaper publishing industry includes companies that publish and market news journals and daily/weekly newspapers. News Corporation, New York Times Company, and Gannett Co., Inc. are some of the largest newspaper publishers. Commercial ad revenue helps to cover plant and equipment costs and general and administrative expense. The popularity and distribution network of newspaper publishers could affect the fees they can charge on advertisements. In recent decades, with digital content grabbing advertising dollars, long-standing publishing companies have increasingly diversified into creating their own web-based content to stay in business.

Market Cap

The average market capitalization across the Publishing: Newspapers Industry is 2.92B. The market cap for tickers in the group ranges from 3.77K to 14.41B. IFPJF holds the highest valuation in this group at 14.41B. The lowest valued company is XLMDF at 3.77K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Newspapers Industry was 0%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -5%. TNMG experienced the highest price growth at 86%, while NYT experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Publishing: Newspapers Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was -88% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 47
Price Growth Rating: 54
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: -47 (-100 ... +100)
View a ticker or compare two or three
SCHL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a publisher of books, magazines, teacher materials and television programming for children

Industry PublishingNewspapers

Industry
Publishing Books Or Magazines
Address
557 Broadway
Phone
+1 212 343-6100
Employees
6905
Web
https://www.scholastic.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.